,,ii  #aahth ,,congress  #ast ,session  
,s4 #caca  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,october #be1  
#bjbc,mr4 ,barrasso 7for himself and    
,mr4 ,carper7 introduced the following  
bill2 which was read twice and referred 
to the ,committee on ,finance  ,a ,,bill
  ,to amend title ,,xi of the ,social   
,security ,act to expand and clarify the
 exclusion for orphan drugs under the   
,drug ,price ,negotiation ,program4  #a4
 ,short title ,this ,act may be cited as
 the ,optimizing ,research ,progress    
,hope ,and ,new ,cures ,act or the      
,,orphan ,cures ,act4  #b4 ,expanding   
and clarifying the exclusion for orphan 
drugs under the ,drug ,price            
,negotiation ,program ,section #aaib7;e7
 of the ,social ,security ,act 7#db     
,u4,s4,c4 #acbj;f-#a7;e77 is amended--  
7#a7 in paragraph 7#a71 by adding at the
 end the following new subparagraph3    
7,c7 ,treatment of former orphan drugs  
,in calculating the amount of time that 
has elapsed with respect to the approval

 of a drug or licensure of a biological 
product under subparagraph 7,a77ii7 and 
subparagraph 7,b77ii71 respectively1 the
 ,secretary shall not taken into account
 any period during which such drug or   
product was a drug described in         
paragraph 7#c77;,a74  2 and  7#b7 in    
paragraph 7#c77;,a7-- 7,a7 by striking  
only one rare disease or condition and  
inserting one or more rare diseases or  
conditions2 and  7,b7 by striking such  
disease or condition and inserting one  
or more rare diseases or conditions 7as 
such term is defined in section         
#ebf7;a77#b7 of the ,federal ,food1     
,drug1 and ,cosmetic ,act74